Free Trial

Antibe Therapeutics (ATE) Insider Trading & Ownership

→ Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad)
Free ATE Stock Alerts
C$0.30
0.00 (0.00%)
(As of 04/23/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades

Antibe Therapeutics (TSE:ATE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.94%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
C$19,600.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get ATE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Antibe Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ATE Insider Buying and Selling by Quarter

Ad Stansberry Research
“Retirement Secret” Showed 995% Gain Last Time We Shared It
See this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)
Get the free details now.

Antibe Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/7/2024Daniel Marcel LegaultDirectorBuy20,000C$0.50C$10,000.00
3/6/2024Joseph StaufferSenior OfficerBuy24,000C$0.40C$9,600.00
(Data available from 1/1/2013 forward)

ATE Insider Trading Activity - Frequently Asked Questions

Who is on Antibe Therapeutics's Insider Roster?

The list of insiders at Antibe Therapeutics includes Daniel Marcel Legault, John Lawrence Wallace, Joseph Stauffer, Scott Wilson Curtis, and Walter Minnes Macnee. Learn more on insiders at ATE.

What percentage of Antibe Therapeutics stock is owned by insiders?

7.94% of Antibe Therapeutics stock is owned by insiders. Learn more on ATE's insider holdings.

Which Antibe Therapeutics insiders have been buying company stock?

The following insiders have purchased ATE shares in the last 24 months: Daniel Marcel Legault (C$33,900.00), Joseph Stauffer (C$9,600.00), and Scott Wilson Curtis (C$22,400.00).

How much insider buying is happening at Antibe Therapeutics?

Insiders have purchased a total of 131,500 ATE shares in the last 24 months for a total of C$65,900.00 bought.

Which Antibe Therapeutics insiders have been selling company stock?

The following insider sold ATE shares in the last 24 months: John Lawrence Wallace (C$16,430.00).

How much insider selling is happening at Antibe Therapeutics?

Insiders have sold a total of 26,500 Antibe Therapeutics shares in the last 24 months for a total of C$16,430.00 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (TSE:ATE) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
“The Biggest Bubble of All Time” – Here’s What to Do.
Chaikin Analytics
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Better than Bitcoin? The Biotech Stock with 46,751% Potential
Behind the Markets
Global crypto currency reset (41 major banks signed up)
Stansberry Research
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press